AstraZeneca stock sinks 3.5% after Q3 earnings

Friday, 12. November 2021 10:38

The shares of COVID-19 vaccine maker AstraZeneca plc plunged more than 3.5% during the last trading session of the week after the company reported its third-quarter financial results.

In a release published ahead of today's opening bell, AstraZeneca revealed it earned over $1 billion in sales of its COVID-19 vaccine during the trimester ending September 30, and announced plans to separate vaccines and antibody treatments units to further focus on addressing the coronavirus pandemic.

AstraZeneca's stocks dropped 3.57% to sell for £91.07 a share at 10:20 am CET, leading the flop table on the FTSE 100.

Related Links: AstraZeneca plc
Author:
Baha Breaking the News (BBN) / ND